GDC-0077 Uses, Dosage, Side Effects and more

GDC-0077 is under investigation in clinical trial NCT03006172 (To Evaluate the Safety, Tolerability, and Pharmacokinetics of GDC-0077 Single Agent in Participants With Solid Tumors and in Combination With Endocrine and Targeted Therapies in Participants With Breast Cancer).

Trade Name GDC-0077
Generic GDC-0077
Type
Formula C18H19F2N5O4
Weight Average: 407.378
Monoisotopic: 407.140510438
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Innovators Monograph

*** Taking medicines without doctor's advice can cause long-term problems.
Share